Villya develops patented reformulated drugs with improved solubility and delivery in liquid, topical, and injectable forms.
Villya has raised $250K in total funding. The most recent round was Seed. The last funding was announced in December 2023.
Villya is headquartered in Melbourne, United States.
Villya develops patented reformulated drugs with improved solubility and delivery in liquid, topical, and injectable forms.
Villya is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Villya — Funding & Investors." VCBacked, December 18, 2023, https://www.vcbacked.co/company/villya. Accessed August 14, 2026.
VCBacked. (2023). Villya — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/villya
{{cite web |title=Villya — Funding & Investors |url=https://www.vcbacked.co/company/villya |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated